Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation

BACKGROUND: Delayed graft function, the requirement for dialysis due to poor kidney function post-transplant, is a frequent complication of deceased donor kidney transplantation and is associated with inferior outcomes and higher costs. Intravenous fluids given during and after transplantation may a...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Michael G., Fahim, Magid A., Pascoe, Elaine M., Dansie, Kathryn B., Hawley, Carmel M., Clayton, Philip A., Howard, Kirsten, Johnson, David W., McArthur, Colin J., McConnochie, Rachael C., Mount, Peter F., Reidlinger, Donna, Robison, Laura, Varghese, Julie, Vergara, Liza A., Weinberg, Laurence, Chadban, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249430/
https://www.ncbi.nlm.nih.gov/pubmed/32450917
http://dx.doi.org/10.1186/s13063-020-04359-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249430/
https://www.ncbi.nlm.nih.gov/pubmed/32450917
http://dx.doi.org/10.1186/s13063-020-04359-2

Ejemplares similares